Vyvanse Generic: Is There a Generic for Vyvanse? | VyvansePills.com
Generic Guide

Is There a Generic
for Vyvanse?

✓ Direct Answer
Yes. The generic for Vyvanse is lisdexamfetamine dimesylate — the identical active ingredient, same prodrug mechanism, same 13 dosage strengths, same 12-14 hour duration. FDA-approved generics are required by law to be bioequivalent to the brand-name drug.
13
Available strengths
from $140
Per 30-day supply
100%
Same active ingredient
2023
Generic availability year
Drug Identity
Brand NameVyvanse
Generic NameLisdexamfetamine Dimesylate
Active IngredientIdentical
MechanismIdentical (Prodrug)
Duration12-14 hours
Strengths10mg – 70mg (13 total)
FormsCapsule + Chewable
DEA ScheduleSchedule II
FDA Bioequivalent✓ Yes
Generic name
Lisdexamfetamine dimesylate
Same as brand?
Yes — FDA bioequivalent
Available since
2023 (patent expiry)
Starting price
$140.88 / 30-day supply
Strengths
10mg – 70mg · 13 options

What Is Generic Vyvanse?

Generic Vyvanse is lisdexamfetamine dimesylate — the same active pharmaceutical ingredient (API) that powers brand-name Vyvanse, manufactured by generic pharmaceutical companies after Takeda’s patent exclusivity on Vyvanse expired in 2023.

Under FDA law, a generic drug must be bioequivalent to the brand-name reference drug. This means the generic delivers the same amount of the same active ingredient into the bloodstream at essentially the same rate. The therapeutic effect, duration, and mechanism are identical. The only things that can legally differ are the inactive ingredients (fillers, dyes, coatings), the appearance, and the price.

When your prescription says “Vyvanse” and your pharmacy substitutes lisdexamfetamine dimesylate, they are dispensing the same drug — not a substitute or approximation.

What Is Identical Between Brand & Generic
100%
Same active ingredient (lisdexamfetamine dimesylate)
100%
Same prodrug mechanism of action
13
Identical dosage strengths available
12-14h
Same duration per dose

Brand Name Vyvanse vs Generic Lisdexamfetamine

Here is exactly what is the same and what differs between brand-name Vyvanse and generic lisdexamfetamine dimesylate.

Brand Name
Vyvanse®
by Takeda Pharmaceuticals
Active ingredient: Lisdexamfetamine dimesylate
Mechanism: Prodrug converted in RBCs to dextroamphetamine
Duration: 12-14 hours
Strengths: 10mg-70mg capsules, 10mg-60mg chewable
DEA Schedule: Schedule II
Price: Higher — original brand pricing
Manufacturer: Takeda only
Appearance: Takeda’s specific capsule/tablet design
Generic
Lisdexamfetamine Dimesylate
FDA-approved generic equivalents
Active ingredient: Lisdexamfetamine dimesylate (identical)
Mechanism: Same prodrug conversion — identical therapeutic effect
Duration: 12-14 hours (bioequivalent)
Strengths: All 13 strengths available
DEA Schedule: Schedule II (same legal class)
Price: More accessible — from $140.88
Manufacturer: Multiple FDA-approved manufacturers
Inactive ingredients: May differ (fillers, dyes) — no therapeutic impact
Bottom line: The only clinically meaningful differences are in inactive ingredients (which have no pharmacological effect) and price. Therapeutically, brand Vyvanse and generic lisdexamfetamine dimesylate perform identically.

How Generic Lisdexamfetamine Works

Generic lisdexamfetamine dimesylate works through the exact same prodrug mechanism as brand-name Vyvanse — because it is the same molecule working through the same biological pathway.

Prodrug Mechanism — Identical in Brand & Generic
1

Ingested as an Inactive Prodrug

Lisdexamfetamine dimesylate is pharmacologically inert at ingestion. No stimulant effect occurs immediately after swallowing — identical whether the capsule says “Vyvanse” or “lisdexamfetamine dimesylate”.

2

Absorbed into the Bloodstream

The inactive molecule is absorbed through the GI tract and binds to red blood cells in the bloodstream. Food and gastric pH have no meaningful effect on absorption.

3

Enzymatic Conversion to Active Dextroamphetamine

Red blood cell peptidase enzymes gradually cleave the l-lysine amino acid, releasing active dextroamphetamine at a slow, rate-limited pace. This biological ceiling creates smooth, prolonged coverage without sharp peaks.

4

Dopamine & Norepinephrine Increase in Prefrontal Cortex

Dextroamphetamine crosses the blood-brain barrier and increases dopamine and norepinephrine availability — improving focus, impulse control, and executive function in ADHD patients.

5

12-14 Hours of Stable Symptom Coverage

Gradual onset (1-2 hrs), smooth sustained peak (3-5 hrs), and gradual taper — single morning dose covers the full day without an abrupt crash.

FDA Bioequivalence — What It Means

The FDA’s generic drug approval process is rigorous. Before any generic lisdexamfetamine dimesylate can be sold, the manufacturer must prove to the FDA that their product meets strict bioequivalence standards through human pharmacokinetic studies.

⚗️
±20% AUC
Maximum allowed deviation in total drug exposure between brand and generic (area under the curve)
⏱️
Same Cmax
Peak drug concentration must be equivalent within the FDA’s accepted statistical confidence interval
🔬
In vivo testing
Human pharmacokinetic studies required — not just lab tests — before FDA approval is granted

In practice, approved generics are typically within 3-5% of the brand drug’s performance. The ±20% threshold is a regulatory ceiling, rarely approached by approved generics.

Same active ingredient (lisdexamfetamine dimesylate)
Same strength and dosage form
Same route of administration (oral)
Same labeling (conditions of use, warnings)
Demonstrated bioequivalence in human studies
FDA-inspected manufacturing facility

Generic Vyvanse Prices — All 13 Strengths

All 13 lisdexamfetamine dimesylate dosage strengths are in stock at VyvansePills.com — oral capsules (10mg-70mg) and chewable tablets (10mg-60mg). Prices are per 30-day supply.

Strength Form Typical Use Price / 30-day Order
10mgChewablePediatric starter / sensitive patients$140.88Order →
10mgCapsulePediatric starter / sensitive patients$158.88Order →
20mgChewableStandard pediatric starting dose$165.88Order →
20mgCapsuleStandard pediatric starting dose$215.88Order →
30mgChewableMost common adult starting dose$195.88Order →
30mgCapsuleMost common adult starting dose$245.88Order →
40mgChewableAdult maintenance dose$225.88Order →
40mgCapsuleAdult maintenance dose$245.88Order →
50mgChewableHigher clinical response needed$260.88Order →
50mgCapsuleHigher clinical response needed$320.88Order →
60mgChewableHigher body weight / extended needs$295.88Order →
60mgCapsuleHigher body weight / extended needs$365.88Order →
70mgCapsuleMaximum FDA dose — adults only$410.88Order →
Free shipping on orders over $300. All orders ship in plain, discreet packaging with no medication names visible on the outside. Orders typically ship within 1-2 business days. See the full shipping policy →

Who Should Consider Generic Lisdexamfetamine?

Good candidates for the generic

Patients currently prescribed brand Vyvanse seeking a lower-cost alternative
New ADHD patients starting lisdexamfetamine for the first time
Patients whose insurance does not cover brand Vyvanse
Adults requiring the 70mg maximum dose
Children who prefer the chewable tablet format
Anyone who responded well to Vyvanse and wants to continue treatment

Discuss with your prescriber when

Known sensitivity to specific dyes or fillers — review inactive ingredient list
Prior inconsistent response when switching between generic manufacturers
Prescriber has written “Dispense As Written” (DAW) on the prescription
Patient condition requires tightly controlled dosing consistency

Frequently Asked Questions About Generic Vyvanse

Yes. The FDA-approved generic for Vyvanse is lisdexamfetamine dimesylate. It became available in the United States in 2023 after Takeda’s patent exclusivity expired. Generic lisdexamfetamine is available in all 13 strengths as both oral capsules and chewable tablets.
The generic name is lisdexamfetamine dimesylate. “Vyvanse” is the brand name used by Takeda Pharmaceuticals. On your prescription, the generic may appear as “lisdexamfetamine”, “lisdexamfetamine dimesylate”, or “LDX”. All refer to the same active compound.
Yes. The FDA requires generic drugs to demonstrate bioequivalence to the brand-name reference drug. Approved generics typically deviate less than 5% from the brand drug in pharmacokinetic studies — well within the FDA’s acceptable range. The therapeutic effect, duration, and side effect profile are identical.
Generic lisdexamfetamine dimesylate became available in the US in 2023 after Takeda’s core Vyvanse patents expired. Prior to this, Vyvanse was available only as the brand-name product since its 2007 FDA approval. Multiple generic manufacturers now produce FDA-approved versions.
In most cases, yes. If your prescription says “Vyvanse” without a “Dispense As Written” (DAW) notation, your pharmacist can substitute an FDA-approved generic. The FDA has classified generic lisdexamfetamine as therapeutically equivalent (AB-rated) to brand Vyvanse. If your prescriber added DAW, the brand must be dispensed — ask your prescriber if you want to switch.
Yes, the appearance can differ. Generic manufacturers are permitted to use different capsule colors, tablet shapes, and imprints from the brand. This is expected and does not indicate a problem. The active ingredient, strength, and therapeutic effect are identical regardless of appearance.
Yes — they are the exact same molecule. Vyvanse is the brand name Takeda chose for their lisdexamfetamine dimesylate product. When you take generic lisdexamfetamine dimesylate, you are taking the same drug that Takeda developed and sells under the Vyvanse brand name.
Prices start at $140.88 for 10mg chewable tablets per 30-day supply. Oral capsules start at $158.88 for 10mg. The maximum 70mg capsule dose is $410.88. All 13 strengths are in stock. Orders over $300 qualify for free shipping.

Shop Generic Vyvanse — All 13 Strengths In Stock

Lisdexamfetamine dimesylate oral capsules 10mg-70mg and chewable tablets 10mg-60mg. Same active ingredient as brand Vyvanse. Discreet shipping, secure checkout.

Medical Disclaimer: This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Lisdexamfetamine dimesylate is a DEA Schedule II controlled substance requiring a valid prescription. All substitution decisions — including switching from brand-name Vyvanse to generic lisdexamfetamine — should be made in consultation with a licensed healthcare provider. VyvansePills.com does not provide prescriptions or medical consultations.